Guangzhou General Pharmaceutical Research Institute


Pharmaceutical Services

In 1990, we established Guangzhou Pharmaceutical R & D Center of Controlled Release Dosage Forms with supporting from Guangzhou Scientific Committee and China State Pharmaceutical Administration (now called as SFDA). Since that time, we have developed near twenty extended release formulations and obtained Approval Certificates of New Drugs from the State Food and Drug Administration (SFDA). Most of them have been licensed to domestic pharmaceutical companies, and some of them to the companies in Hong Kong. The main extended release products we have developed and marketed are as follows: SR fexofenadine and pseudoephedrine Cap., CR metoprolol, CR diltiazem, SR metformin, CR salbutamol, SR naproxen, SR ibuprofen, SR theopylline, and mesalazine enteric tablets and so on. Additionally, GPRI holds many Chinese Patents for formulation technologies and products.

    >> more...

 Add Company to Favorites